A randomized, double-blind, multicenter Phase II study comparing the efficacy and safety of oral nemonoxacin with oral levofloxacin in the treatment of community-acquired pneumonia

A randomized, double-blind, multicenter Phase II study comparing the efficacy and safety of oral nemonoxacin with oral levofloxacin in the treatment of community-acquired pneumonia

Background/Purpose: To compare the clinical efficacy and safety of nemonoxacin with levofloxacin in treating community-acquired pneumonia (CAP) in a Phase II clinical trial. Methods: One hundred ninety-two patients with CAP were randomized to receive oral nemonoxacin (500 mg or 750 mg) or levoflox...

Full description

Bibliographic Details
Main Authors: Yang Liu, Yingyuan Zhang, Jufang Wu, Demei Zhu, Shenghua Sun, Li Zhao, Xuefeng Wang, Hua Liu, Zhenyi Ren, Changzheng Wang, Qingyu Xiu, Zuke Xiao, Zhaolong Cao, Shehuai Cui, Heping Yang, Yongjie Liang, Ping Chen, Yuan Lv, Chengping Hu, Xiaoju Lv, Shuang Liu, Jiulong Kuang, Jianguo Li, Dexi Wang, Liwen Chang
Format: Article
Language:English
Published: Elsevier 2017-12-01
Series:Journal of Microbiology, Immunology and Infection
Online Access:http://www.sciencedirect.com/science/article/pii/S1684118215009159

Internet

http://www.sciencedirect.com/science/article/pii/S1684118215009159

Similar Items